Indian Council of Medical Research Facilitates Licensing of 3 Indigenous Biomedical Technologies
News Context
At a glance
- The Indian Council of Medical Research (ICMR) has licensed three indigenous biomedical technologies to two domestic pharmaceutical companies, Emcure and Biological E, for commercial development.
- The licensing agreement, facilitated by ICMR, involves the transfer of technologies for a cervical cancer drug and vaccine, as reported by The Economic Times and BusinessLine.
- The specific technologies licensed remain undisclosed in public reports.
The Indian Council of Medical Research (ICMR) has licensed three indigenous biomedical technologies to two domestic pharmaceutical companies, Emcure and Biological E, for commercial development. The transfer includes technologies related to cervical cancer and vaccines.
The licensing agreement, facilitated by ICMR, involves the transfer of technologies for a cervical cancer drug and vaccine, as reported by The Economic Times and BusinessLine. Additionally, the ICMR has granted licenses for cancer and vaccine technologies to the same companies, according to ETPharma.com.
Details of the Licensed Technologies
The specific technologies licensed remain undisclosed in public reports. BusinessLine noted that the technologies are described as “indigenous.”